These studies suggest that MLH1 may act as a protective factor, with higher expression potentially reducing the risk and improving the prognosis of osteosarcoma patients, while SQLE may serve as a risk factor, with its higher expression possibly increasing the prognosis risk for osteosarcoma patients. The gene discussed is MLH1; the disease is osteosarcoma.